Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 50,979 | 3,517 | 3,363 | 6,765 | 3,523 |
| Operating Income | -50,979 | -3,517 | -3,363 | -6,765 | -3,523 |
| Interest Expense | 5 | 0 | 5 | 0 | 57 |
| Other Income | 1,423 | 805 | 2,460 | 3,514 | -802 |
| Pre-tax Income | -49,560 | -2,712 | -908 | -3,251 | -4,383 |
| Net Income Continuous | -42,106 | -2,712 | -908 | -3,251 | -4,383 |
| Net Income | $-42,106 | $-2,712 | $-908 | $-3,251 | $-4,383 |
| EPS Basic Total Ops | -15,415.46 | -1,063.69 | -383.36 | -1,799.82 | -6,749.33 |
| EPS Basic Continuous Ops | -15,425.80 | -1,063.58 | -382.95 | -1,803.43 | -6,821.50 |
| EPS Diluted Total Ops | -15,415.46 | -1,063.69 | -383.36 | -1,799.82 | -6,749.33 |
| EPS Diluted Continuous Ops | -15,425.80 | -1,063.58 | -382.95 | -1,803.43 | -6,821.50 |
| EBITDA(a) | $-12,102 | $-3,343 | $-3,189 | $-6,628 | $-3,400 |